Rockets and Duds: Week 22 - June 2, 2025
5i Research Weekly Rockets and Duds This week's 5i Research Rockets and...
Stock Research
Knight Therapeutics has been a name that has tested investors' patience. While its no debt and high cash offer plenty of protection to the...
Operating in a stagnant growth industry is hard enough, and with a large cash balance and no M&A activity over the past decade made Winpak's...
The strategy of "simplicity is the best" is far too forgotten in the investment world. In this blog, we talk about three stocks that are at...
Looking for more? Sign up for a FREE 14 day trial! No credit card required
We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!
More from 5i Research
5 from 5i: 11 Ways Retirees Damage Their Retirement Success
Weekly stock market update & five stock related articles we thought were a must-read this...
Rockets and Duds: Week 21 - May 27, 2025
5i Research Weekly Rockets and Duds This week's 5i Research Rockets and...